Literature DB >> 20483546

Substance abusers' motives for using anabolic androgenic steroids.

Anna Petersson1, Johanna Bengtsson, Anette Voltaire-Carlsson, Ingemar Thiblin.   

Abstract

BACKGROUND: The use of anabolic androgenic steroids (AAS) has been associated with the use of illegal drugs. Earlier observations suggested that users of illegal drugs may use AAS for reasons other than increasing muscle strength or size. The aim of the present study was to investigate the motives for AAS use among outpatients at a substance abuse center in Stockholm, Sweden.
METHODS: All male patients under the age of 50 were asked whether they had used AAS during a 2-month period. An AAS survey was administered to those who reported AAS experiences in the admittance interview.
RESULTS: Twenty of the 175 respondents (11%) reported using AAS. The most frequently reported motives were related to anabolic effects (i.e., for a good-looking body, to become stronger, or to perform better in sports). However, some users reported other motives; for example, to conceal concomitant drug use, to alleviate insecurity or low self-esteem, to become brave, or in preparation of committing a crime. Furthermore, many respondents reported side effects that were associated with AAS; most notably, irritability and depression/suicidal ideation.
CONCLUSION: Some users of illicit drugs also use AAS for reasons other than the anabolic properties of these compounds. Therefore, considering that AAS may cause or contribute to diverse morbidity, it is important to ask users of illicit drugs about AAS use, even when obvious external signs of AAS use are lacking. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483546     DOI: 10.1016/j.drugalcdep.2010.04.008

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

1.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

Review 2.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

3.  Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings.

Authors:  Daria Piacentino; Gabriele Sani; Georgios D Kotzalidis; Simone Cappelletti; Livia Longo; Salvatore Rizzato; Francesco Fabi; Paola Frati; Vittorio Fineschi; Lorenzo Leggio
Journal:  Hum Psychopharmacol       Date:  2021-09-15       Impact factor: 2.130

4.  Anabolic steroids among resistance training practitioners.

Authors:  Ericson Pereira; Samuel Jorge Moyses; Sérgio Aparecido Ignácio; Daniel Komarchewski Mendes; Diego Sgarbi da Silva; Everdan Carneiro; Ana Maria Trindade Grégio Hardy; Edvaldo Antônio Ribeiro Rosa; Patrícia Vida Cassi Bettega; Aline Cristina Batista Rodrigues Johann
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

5.  Prevalence and profile of users and non-users of anabolic steroids among resistance training practitioners.

Authors:  Ericson Pereira; Samuel Jorge Moyses; Sérgio Aparecido Ignácio; Daniel Komarchewski Mendes; Diego Sgarbi D A Silva; Everdan Carneiro; Ana Maria Trindade Grégio Hardy; Edvaldo Antônio Ribeiro Rosa; Patrícia Vida Cassi Bettega; Aline Cristina Batista Rodrigues Johann
Journal:  BMC Public Health       Date:  2019-12-09       Impact factor: 3.295

6.  Recruitment to doping and help-seeking behavior of eight female AAS users.

Authors:  Annica Börjesson; Nina Gårevik; Marja-Liisa Dahl; Anders Rane; Lena Ekström
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-03-05

7.  Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality.

Authors:  Annica Börjesson; Christian Möller; Anders Hagelin; Veronica Vicente; Anders Rane; Mikael Lehtihet; Marja-Liisa Dahl; Nina Gårevik; Lena Ekström
Journal:  Medicina (Kaunas)       Date:  2020-05-28       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.